CLIENT PRESS: WRAL TechWire Announces First Flight Venture Center Resident Company Receives $3.2M in SBIR Grants
NovaTarg, a First Flight Venture Center resident company that develops new treatments for cancer, kidney disease and diabetes has received $3.2M in Small Business Innovative Research grants, tripling the firm’s current funding. |